Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
IN BRIEF: ImmuPharma raises GBP950,000 from broker option
ImmuPharma PLC - specialist drug discovery and development company - Raises GBP950,000 under broker option, taking total proceeds from placing and broker option to GBP1.04 million. "Further to the announcement of August 3, 2022, the directors confirm that the fundraising, together with existing funding and funding arrangements, will provide the company with sufficient working capital for at least the next 12 months," it says.
Current stock price: 5.17 pence
12-month change: down 45%
By Lucy Heming; lucyheming@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
Immupharma Shares in this article
Latest News
- Nature Energy buys 39% stake in Kazakh miner ERG
9 hours ago - Sunday newspaper round-up: Food prices, Modella Capital, Iran peace deal, Nigel Farage, White House shooting, Rachel Reeves, EU
12 hours ago - UK floated single market for goods with EU, media say
1 day ago - US close: Stocks rise on peace deal hopes, Dow hits another record
1 day ago - BP's Whiting Refinery offers revised proposal to union in ongoing talks
1 day ago - IN BRIEF: Surface Transforms enters asset sale transaction agreement
1 day ago - GLOBAL MARKETS-Stocks climb, yields dip as investors focus on some progress in US-Iran talks
1 day ago
Related News
WINNERS & LOSERS: Ramsdens ups profit view; Reach revenue falls
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.
Predator Oil
IN BRIEF: ImmuPharma forecasts "year of delivery" in 2026
ImmuPharma PLC - London-based specialist drug discovery and development company - Chair Tim McCarthy produces open letter to shareholders, noting that...
ImmuPharma shares rise on patent milestone and "supportive" study
(Alliance News) - ImmuPharma PLC on Friday announced a "supportive response" to its UK patent application for P140, which was itself supported by "pos...
Follow the stocks
